Filters
Other countries
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Natera, Inc. United States | 244 | 254 |
|
Natera, Inc. United States | 265 | 275 |
|
Natera, Inc. United States | 265 | 274 |
|
Natera, Inc. United States | 265 | 274 |
|
Fulgent Genetics United States | 79 | 45 |
|
Aromatase Deficiency (CYP19A1 Single Gene Test) Fulgent Genetics United States | 2 | 1 |
|
Fulgent Genetics United States | 92 | 56 |
|
Fulgent Genetics United States | 76 | 41 |
|
Beacon Expanded Female Carrier Screening Plus Panel Fulgent Genetics United States | 716 | 335 |
|
Beacon Expanded Male Carrier Screening Panel Fulgent Genetics United States | 636 | 298 |
|
Beacon Expanded Male Carrier Screening Plus Panel Fulgent Genetics United States | 661 | 306 |
|
Beacon Expanded Female Carrier Screening Panel Fulgent Genetics United States | 690 | 326 |
|
Premature Ovarian Failure (POF) and Related Disorders , Panel Massive Sequencing (NGS) 14 Genes Reference Laboratory Genetics Spain | 14 | 14 |
|
Laboratorio de Genetica Clinica SL Spain | 1 | 1 |
|
Aromatase Deficiency, Sequencing CYP19A1 Gene Reference Laboratory Genetics Spain | 1 | 1 |
|
Abnormal/Ambiguous Genitalia Panel Genetic Services Laboratory University of Chicago United States | 81 | 92 |
|
CeGaT GmbH Germany | 2 | 1 |
|
Bioarray Spain | 1 | 1 |
|
Fulgent Genetics United States | 2 | 1 |
|
Fulgent Genetics United States | 5129 | 4672 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.